NovaBridge Biosciences NBP
NASDAQ NBP
$1.33 -0.04 (-2.92%)
At close: Oct 22, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Operating Margin (2019 - 2023)

Updated

NovaBridge Biosciences (NBP) posted Operating Margin of -789260.00% for Q4 2023, down 785884.13 percentage points from the prior quarter.

Analysis

NovaBridge Biosciences (NBP) Operating Margin (2019 - 2023) Analysis & Trends

For FY2023, NovaBridge Biosciences' Operating Margin came in at -11395.09%, down 7972.92 percentage points from FY2022.

  • Annual Operating Margin has declined for three consecutive years, with a five-year change of -10579.49 percentage points (FY2018 to FY2023).
  • In prior years, NovaBridge Biosciences' Operating Margin was -3422.18% in FY2022 (-1097.39 pp), -2324.79% in FY2021 (-2319.51 pp), -5.27% in FY2020 (+4878.23 pp) and -4883.50% in FY2019 (-4067.90 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 24.35%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 37.86%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 20.57%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 28.37%
10 NovaBridge Biosciences 126.41 Mn -669.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -789,260.00%
Sep 30, 2023 -3,375.87%
Jun 30, 2023 -7,578.62%
Dec 31, 2020 60.24%
Sep 30, 2019 -2,042.94%
API Access

NovaBridge Biosciences Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=NBP&period=max&api_key=YOUR_API_KEY